Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer

Small, EJ; Saad, F; Chowdhury, S; Oudard, S; Hadaschik, BA; Graff, JN; Olmos, D; Mainwaring, PN; Lee, JY; Uemura, H; De Porre, P; Smith, AA; Zhang, K; Lopez-Gitlitz, A; Smith, MR

Small, EJ (reprint author), UCSF, Helen Diller Family Comprehens Canc Ctr, Dept Med, Div Hematol Oncol, 1450 3rd St, San Francisco, CA 94158 USA.

ANNALS OF ONCOLOGY, 2019; 30 (11): 1813

Abstract

Background: In the SPARTAN study, compared with placebo, apalutamide added to ongoing androgen deprivation therapy significantly prolonged metastasis-......

Full Text Link